Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment.

Fariha, Atqiya; Hami, Ithmam; Tonmoy, Mahafujul Islam Quadery; Akter, Shahana; Al Reza, Hasan; Bahadur, Newaz Mohammed; Rahaman, Md Mizanur; Hossain, Md Shahadat

Fariha, Atqiya; Hami, Ithmam; Tonmoy, Mahafujul Islam Quadery; Akter, Shahana; Al Reza, Hasan; Bahadur, Newaz Mohammed; Rahaman, Md Mizanur; Hossain, Md Shahadat.

Afiliación

Fariha A; Department of Biotechnology & Genetic Engineering, Noakhali Science and Technology University, Noakhali, Bangladesh.
Hami I; Department of Biotechnology & Genetic Engineering, Noakhali Science and Technology University, Noakhali, Bangladesh.
Tonmoy MIQ; Department of Biotechnology & Genetic Engineering, Noakhali Science and Technology University, Noakhali, Bangladesh.
Akter S; Department of Biotechnology & Genetic Engineering, Noakhali Science and Technology University, Noakhali, Bangladesh.
Al Reza H; Department of Genetic Engineering and Biotechnology, University of Dhaka, Dhaka, Bangladesh.
Bahadur NM; Department of Applied Chemistry and Chemical Engineering, Noakhali Science and Technology University, Noakhali, Bangladesh.
Rahaman MM; Department of Microbiology, University of Dhaka, Dhaka, Bangladesh.
Hossain MS; Department of Biotechnology & Genetic Engineering, Noakhali Science and Technology University, Noakhali, Bangladesh.

Heliyon ; 8(10): e11081, 2022 Oct.

Article en En | MEDLINE | ID: mdl-36303933

Palabras clave

Biomarker; Cancer therapy; Cell cycle; NSCLC; miRNA

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies / Screening_studies Idioma: En Revista: Heliyon Año: 2022 Tipo del documento: Article País de afiliación: Bangladesh Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google